UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Crimean-Congo haemorrhagic fever virus

Nature reviews. Microbiology, 2023-07, Vol.21 (7), p.463-477

2023

Volltextzugriff (PDF)

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model

Nature communications, 2021-04, Vol.12 (1), p.2295-2295, Article 2295

2021

Volltextzugriff (PDF)

Recent advances in understanding Crimean-Congo hemorrhagic fever virus [version 1; peer review: 4 approved]

F1000 research, 2018, Vol.7, p.1715

2018

Volltextzugriff (PDF)

Chronic Joint Disease Caused by Persistent Chikungunya Virus Infection Is Controlled by the Adaptive Immune Response

Journal of Virology, 2013-12, Vol.87 (24), p.13878-13888

2013

Volltextzugriff (PDF)

A Look into Bunyavirales Genomes: Functions of Non-Structural (NS) Proteins

Viruses, 2021-02, Vol.13 (2), p.314

2021

Volltextzugriff (PDF)

An Alphavirus -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates

Science translational medicine, 2020-08, Vol.12 (555)

2020

Volltextzugriff (PDF)

Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques

PLoS pathogens, 2022-04, Vol.18 (4), p.e1010155-e1010155

2022

Volltextzugriff (PDF)

Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model

Molecular therapy, 2023-02, Vol.31 (2), p.387-397

2023

Volltextzugriff (PDF)

Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence

Journal of virology, 2019-09, Vol.93 (18)

2019

Volltextzugriff (PDF)

Favipiravir and Ribavirin protect immunocompetent mice from lethal CCHFV infection

Antiviral research, 2023-10, Vol.218, p.105703-105703, Article 105703

2023

Volltextzugriff (PDF)

Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence

Cell reports (Cambridge), 2016-08, Vol.16 (5), p.1326-1338

2016

Volltextzugriff (PDF)

Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus

eLife, 2021-01, Vol.10

2021

Volltextzugriff (PDF)

Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques

Antiviral research, 2020-09, Vol.181, p.104858-104858, Article 104858

2020

Volltextzugriff (PDF)

Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice

Antiviral research, 2018-09, Vol.157, p.18-26

2018

Volltextzugriff (PDF)

Species-specific MARCO-alphavirus interactions dictate chikungunya virus viremia

Cell reports (Cambridge), 2023-05, Vol.42 (5), p.112418-112418, Article 112418

2023

Volltextzugriff (PDF)

Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model

mBio, 2020-03, Vol.11 (2)

2020

Volltextzugriff (PDF)

Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge

EBioMedicine, 2022-08, Vol.82, p.104188-104188, Article 104188

2022

Volltextzugriff (PDF)

SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern

eLife, 2022-02, Vol.11

2022

Volltextzugriff (PDF)

Animal Models of Chikungunya Virus Infection and Disease

The Journal of infectious diseases, 2016-12, Vol.214 (suppl 5), p.S482-S487

2016

Volltextzugriff (PDF)

SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract

Cell reports (Cambridge), 2022-03, Vol.38 (11), p.110515-110515, Article 110515

2022

Volltextzugriff (PDF)

A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model

Nature microbiology, 2021-02, Vol.6 (2), p.187

2021

Volltextzugriff (PDF)

Third International Conference on Crimean-Congo Hemorrhagic Fever in Thessaloniki, Greece, September 19–21, 2023

Antiviral research, 2024-05, Vol.225, p.105844-105844, Article 105844

2024

Volltextzugriff (PDF)

Immunobiology of Crimean-Congo hemorrhagic fever

Antiviral research, 2022-03, Vol.199, p.105244-105244, Article 105244

2022

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(52)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Virology
(7)
Antiviral Research
(5)
Ebiomedicine
(5)
Cell Reports
(3)
Microorganisms
(3)
Elife
(2)
Journal Of Geophysical Research. Biogeosciences
(2)
Mbio
(2)
Nature Microbiology
(2)
Plos Pathogens
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Crimean-Congo haemorrhagic fever virus

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model

Recent advances in understanding Crimean-Congo hemorrhagic fever virus [version 1; peer review: 4 approved]

Chronic Joint Disease Caused by Persistent Chikungunya Virus Infection Is Controlled by the Adaptive Immune Response

A Look into Bunyavirales Genomes: Functions of Non-Structural (NS) Proteins

An Alphavirus -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates

Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques

Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model

Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence

Favipiravir and Ribavirin protect immunocompetent mice from lethal CCHFV infection

Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence

Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus

Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques

A replicon RNA vaccine can induce durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned

Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice

Species-specific MARCO-alphavirus interactions dictate chikungunya virus viremia

Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model

Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge

SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern

Animal Models of Chikungunya Virus Infection and Disease

SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract

A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model

Third International Conference on Crimean-Congo Hemorrhagic Fever in Thessaloniki, Greece, September 19–21, 2023

Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques

Immunobiology of Crimean-Congo hemorrhagic fever

Suchergebnisse filtern